-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Silo Pharma, Inc. quarterly/annual Revenues history and growth rate from Q3 2019 to Q4 2024.
- Silo Pharma, Inc. Revenues for the quarter ending December 31, 2024 was $18K, unchanged year-over-year.
- Silo Pharma, Inc. Revenues for the twelve months ending December 31, 2024 was $72.1K, unchanged year-over-year.
- Silo Pharma, Inc. annual Revenues for 2024 was $72.1K, unchanged from 2023.
- Silo Pharma, Inc. annual Revenues for 2023 was $72.1K, unchanged from 2022.
- Silo Pharma, Inc. annual Revenues for 2022 was $72.1K.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)